Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Delannoy

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Leukemia & Lymphoma|May 1, 1996
Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndromeM Maerevoet, E Van Den Neste, A Delannoy, et al.
Leukemia & Lymphoma|October 29, 2002
Characteristics of secondary acute lymphoblastic leukemia with L3 morphology in adult patientsB Petit, L Mele, K Rack, et al.
Annals of Hematology|March 5, 1998
2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemiaE Van Den Neste, P Martiat, P Mineur, et al.
Acta Cardiologica|January 1, 1982
Adriamycin cardiotoxicity. Prognostic value of the systolic time intervalsJ M Chaudron, M Beauduin, J P Delwiche, et al.
Leukemia|July 1, 1995
2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL)A Delannoy, P Martiat, J L Gala, et al.
Cancer Genetics and Cytogenetics|July 1, 1987
11q-chromosome is associated with abnormal iron stores in myelodysplastic syndromesC Mecucci, A Van Orshoven, K Vermaelen, et al.
European Journal of Haematology|September 1, 1990
High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized studyP Martiat, J M Ghilain, A Ferrant, et al.
Bone Marrow Transplantation|November 1, 1996
Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantationC Ravoet, W Feremans, B Husson, et al.
British Journal of Cancer|July 1, 1994
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'AdulteP Morel, B Dupriez, R Herbrecht, et al.
Leukemia|July 1, 1994
A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remissionB Filleul, A Delannoy, A Ferrant, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Leukemia & Lymphoma|May 1, 1996
Limited activity of mini-dose interferon alpha-2a in the treatment of myelodysplastic syndromeM Maerevoet, E Van Den Neste, A Delannoy, et al.
Leukemia & Lymphoma|October 29, 2002
Characteristics of secondary acute lymphoblastic leukemia with L3 morphology in adult patientsB Petit, L Mele, K Rack, et al.
Annals of Hematology|March 5, 1998
2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemiaE Van Den Neste, P Martiat, P Mineur, et al.
Acta Cardiologica|January 1, 1982
Adriamycin cardiotoxicity. Prognostic value of the systolic time intervalsJ M Chaudron, M Beauduin, J P Delwiche, et al.
Leukemia|July 1, 1995
2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL)A Delannoy, P Martiat, J L Gala, et al.
Cancer Genetics and Cytogenetics|July 1, 1987
11q-chromosome is associated with abnormal iron stores in myelodysplastic syndromesC Mecucci, A Van Orshoven, K Vermaelen, et al.
European Journal of Haematology|September 1, 1990
High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized studyP Martiat, J M Ghilain, A Ferrant, et al.
Bone Marrow Transplantation|November 1, 1996
Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantationC Ravoet, W Feremans, B Husson, et al.
British Journal of Cancer|July 1, 1994
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'AdulteP Morel, B Dupriez, R Herbrecht, et al.
Leukemia|July 1, 1994
A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remissionB Filleul, A Delannoy, A Ferrant, et al.
Pageof 8